ATGVIDEO
Home
Hot video
Now watching
Search
News
Sport
Music
Games
Humor
Animals
Movies
Auto
Home
VJNeurology
VJNeurology
Latest Videos
Clinical comparison of migraine with left- vs right-sided headache
Recent updates in FND diagnosis
P2B001 a slow-release drug for Parkinson’s disease
Pathophysiology of REM sleep behavior disorder
IgA a new biomarker of demyelinating disease
CBT mobile apps to treat insomnia
Recent developments in migraine treatment
Blood pressure updates at ESOC 2023 INTERACT3 and OPTIMAL-BP
Predictors of recovery from post-stroke aphasia
SECRET trial rivaroxaban for cerebral venous thrombosis
Interim data from ECST-2 trial challenges surgical guidelines for carotid stenosis
INTERACT3 results care bundle improves outcomes in intracerebral hemorrhage
Three-month outcomes for patients with chronic pain using cannabis-based medical products
Project T21 unleashing the potential of cannabis-based medicinal products
The impact of diet and exercise on adult hippocampal neurogenesis
Advocating for medical cannabis access and acceptance in the UK
Circadian medicine modifying the circadian rhythm to treat disease
Improvements to levodopa-based treatments for Parkinson’s disease
Results of ocrelizumab in treatment-naïve patients with early relapsing MS
Advancing myasthenia gravis treatment RAISE trial of zilucoplan
Anti-obesity drugs increase adult neurogenesis in the hypothalamus
Extracellular vesicles in Parkinson’s disease
ND0612 vs oral immediate-release levodopacarbidopa in patients with PD and motor fluctuations
MND-SMART the adaptive platform trial investigating potential treatments for MND
Developing a gene therapy for focal cortical dysplasia type II
Investigating the glymphatic system in neurodegenerative diseases
What is the future of immunotherapy in Parkinson’s disease?
Novel brain penetrant capsids for Parkinson’s disease gene therapy
Future of tau-targeting immunotherapies in Alzheimer’s disease
Latest developments in Parkinsons disease biomarkers
Developing antibodies against pathogenic TDP-43 in ALS
Key questions for cell and gene therapy trials in Parkinson’s disease
Open label extension of prasinezumab in Parkinsons disease 1 year updates
Novel combination therapy PrimeC in ALS biomarker data & launch of Phase II trial
Phase I study of selnoflast to slow neurodegeneration in Parkinsons disease
Temporal arteritis treatment duration and disease monitoring
Management of temporal arteritis
Therapy apps for speech and language impairments after stroke
Machine learning-based prediction of cognitive decline in Parkinson’s disease
Progressive MS emerging treatments
What dictates MS progression PIRA vs relapses
Role of oligodendrocytes in demyelination & remyelination in MS future research
GFAP a potential biomarker for progression in MS
COVID-19 and the risk of demyelinating diseases
Quantitative spinal cord magnetic resonance imaging in MS value & challenges
Review of BTK inhibition in MS
Endovascular thrombectomy superior to medical management for large core stroke in SELECT2
ATTICUS subgroup analyses indicate superiority of apixaban over aspirin
Protecting the endothelium as a therapeutic strategy in cerebral small vessel disease
LACI-2 cilostazol and isosorbide mononitrate for the treatment of lacunar stroke
